| Breneshia Braggs, | |
|
3100 Kilpatrick Blvd Ste 102, Monroe, LA 71201-5156 | |
| (318) 325-8050 | |
| Not Available |
| Full Name | Breneshia Braggs |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 3100 Kilpatrick Blvd Ste 102, Monroe, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093317836 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 202142 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Breneshia Braggs, 3100 Kilpatrick Blvd Ste 102, Monroe, LA 71201-5156 Ph: (318) 325-8050 | Breneshia Braggs, 3100 Kilpatrick Blvd Ste 102, Monroe, LA 71201-5156 Ph: (318) 325-8050 |
News Archive
On November 20 at the American Society of Nephrology 43rd Annual Meeting, interim results presented from an ongoing, randomized prospective study conducted independently by James A. Tumlin, MD, at the University of Tennessee College of Medicine Chattanooga indicated that 9 of 15 patients (60%) with advanced diabetic nephropathy who are currently enrolled in the study and have completed or are still undergoing a six month course of treatment with H.P. Acthar ® Gel have exhibited a clinically significant decrease in proteinuria and achieved stabilized renal function.
Masimo announced today that its Board of Directors has declared a special $0.75 per share cash dividend, payable on December 21, 2010 to stockholders of record as of the close of business on December 7, 2010. The total dividend payout is expected to be approximately $44.3 million, based on the current shares outstanding and will be the third instance of a special dividend paid by Masimo in the past four years.
The Affordable Health Care for America Act will make health care more affordable for consumers, hold insurance companies accountable and increase access to health care for millions of Americans.
The USPTO approved a patent for Axiogenesis AG for the invention of its in vitro assay to screen pharmaceutical drug candidates for effectiveness and safety in treating Hypertrophic Cardiomyopathy (HCM).
Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical study in actinic keratosis. This is the Company's third IND to be allowed by the US FDA in the past 12 months.
› Verified 3 days ago
Ann Marie Clack, WHNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 4864 Jackson St, Monroe, LA 71202 Phone: 318-330-7000 | |
Mrs. Delores G Hawthorne, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4800 S Grand St, Monroe, LA 71202 Phone: 318-362-3339 Fax: 318-362-3336 | |
Cynthia Turner, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 920 Oliver Rd, Monroe, LA 71201 Phone: 318-807-6267 Fax: 318-812-6458 | |
Amelia D Adams, RNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1501 Louisville Ave, Monroe, LA 71201 Phone: 318-323-8451 Fax: 318-361-2613 | |
Ms. Sheila S Freeman, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 210 Layton Ave Ste 10, Monroe, LA 71201 Phone: 318-807-0233 Fax: 318-651-7422 | |
Mrs. Teena Harrell-lee, RN-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 28 Martha Dr, Monroe, LA 71203 Phone: 318-235-3956 | |
Lucinda Marie Cook, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 404 Monarch Dr, Monroe, LA 71203 Phone: 318-732-8944 |